Immunology,
Journal Year:
2018,
Volume and Issue:
154(3), P. 363 - 376
Published: March 1, 2018
Summary
Stroke
is
one
of
the
leading
causes
death
and
disability
worldwide.
The
long‐standing
dogma
that
stroke
exclusively
a
vascular
disease
has
been
questioned
by
extensive
clinical
findings
immune
factors
are
associated
mostly
with
inflammation
after
stroke.
These
have
confirmed
in
preclinical
studies
using
experimental
animal
models.
It
now
accepted
mediators
critical
acute
long‐term
neuronal
tissue
damage
healing
following
thrombotic
ischaemic
Despite
mounting
information
delineating
role
system
stroke,
mechanisms
how
inflammatory
cells
their
involved
stroke‐induced
neuroinflammation
still
not
fully
understood.
Currently,
there
no
available
treatment
for
targeting
response
develops
brain
during
cerebral
ischaemia.
No
new
introduced
to
therapy
since
discovery
plasminogen
activator
1996.
Here,
we
review
current
knowledge
immunity
identify
gaps
hinder
therapies.
We
will
discuss
advances
understanding
complex
innate
adaptive
responses
stroke;
cell‐mediated
factor‐mediated
injury;
immunity‐induced
repair;
importance
modulating
International Journal of Molecular Sciences,
Journal Year:
2020,
Volume and Issue:
21(9), P. 3344 - 3344
Published: May 8, 2020
Traumatic
brain
injuries
(TBIs)
account
for
the
majority
of
injury-related
deaths
in
United
States
with
roughly
two
million
TBIs
occurring
annually.
Due
to
spectrum
severity
and
heterogeneity
TBIs,
investigation
into
secondary
injury
is
necessary
order
formulate
an
effective
treatment.
A
mechanical
consequence
trauma
involves
dysregulation
blood–brain
barrier
(BBB)
which
contributes
exposure
peripheral
components
parenchyma.
Recent
studies
have
shed
light
on
mechanisms
BBB
breakdown
TBI
including
novel
intracellular
signaling
cell–cell
interactions
within
niche.
The
current
review
provides
overview
BBB,
detection
methods
disruption,
cellular
molecular
implicated
regulating
its
stability
following
TBI.
CNS Drugs,
Journal Year:
2017,
Volume and Issue:
31(12), P. 1057 - 1082
Published: Dec. 1, 2017
Over
the
past
few
decades,
research
on
Alzheimer's
disease
(AD)
has
focused
pathomechanisms
linked
to
two
of
major
pathological
hallmarks
extracellular
deposition
beta-amyloid
peptides
and
intra-neuronal
formation
neurofibrils.
Recently,
a
third
component,
neuroinflammatory
reaction
mediated
by
cerebral
innate
immune
cells,
entered
spotlight,
prompted
findings
from
genetic,
pre-clinical,
clinical
studies.
Various
proteins
that
arise
during
neurodegeneration,
including
beta-amyloid,
tau,
heat
shock
proteins,
chromogranin,
among
others,
act
as
danger-associated
molecular
patterns,
that—upon
engagement
pattern
recognition
receptors—induce
inflammatory
signaling
pathways
ultimately
lead
production
release
mediators.
These
may
have
beneficial
effects
but
compromise
neuronal
function
cause
cell
death.
The
current
review,
assembled
participants
Chiclana
Summer
School
Neuroinflammation
2016,
provides
an
overview
our
understanding
AD-related
processes.
We
describe
principal
cellular
players
in
inflammation
they
pertain
AD,
examine
modifying
factors,
discuss
potential
future
therapeutic
targets.
Acta Neuropathologica,
Journal Year:
2018,
Volume and Issue:
136(4), P. 507 - 523
Published: Aug. 10, 2018
Many
central
nervous
system
diseases
currently
lack
effective
treatment
and
are
often
associated
with
defects
in
microvascular
function,
including
a
failure
to
match
the
energy
supplied
by
blood
used
on
neuronal
computation,
or
breakdown
of
blood–brain
barrier.
Pericytes,
an
under-studied
cell
type
located
capillaries,
crucial
importance
regulating
diverse
functions,
such
as
angiogenesis,
barrier,
capillary
flow
movement
immune
cells
into
brain.
They
also
form
part
"glial"
scar
isolating
damaged
parts
CNS,
may
have
stem
cell-like
properties.
Recent
studies
suggested
that
pericytes
play
role
neurological
diseases,
thus
therapeutic
target
disorders
stroke,
traumatic
brain
injury,
migraine,
epilepsy,
spinal
cord
diabetes,
Huntington's
disease,
Alzheimer's
multiple
sclerosis,
glioma,
radiation
necrosis
amyotrophic
lateral
sclerosis.
Here
we
report
recent
advances
our
understanding
pericyte
biology
discuss
how
could
be
targeted
develop
novel
approaches
disorders,
increasing
flow,
preserving
barrier
entry
modulating
formation
vessels
in,
glial
around,
regions.
Frontiers in Neuroscience,
Journal Year:
2017,
Volume and Issue:
11
Published: April 21, 2017
Under
physiological
conditions,
the
brain
consumes
over
20%
of
whole
body
energy
supply.
The
blood-brain
barrier
(BBB)
allows
dynamic
interactions
between
blood
capillaries
and
neuronal
network
in
order
to
provide
an
adequate
control
molecules
that
are
transported
out
brain.
Alterations
BBB
structure
function
affecting
accessibility
nutrients
exit
toxins
found
a
number
diseases,
which
turn
may
disturb
nutrient
signaling.
In
this
review
we
explore
major
advances
obtained
understanding
development
how
its
impacts
on
function.
Furthermore,
focus
particularities
permeability
hypothalamus,
role
metabolic
potential
impact
hypothalamic
abnormities
related
diseases.
Frontiers in Aging Neuroscience,
Journal Year:
2020,
Volume and Issue:
12
Published: April 14, 2020
Pericytes
are
unique,
multi-functional
mural
cells
localized
at
the
abluminal
side
of
perivascular
space
in
microvessels.
Originally
discovered
nineteenth
century,
pericytes
had
drawn
less
attention
until
decades
ago
mainly
due
to
lack
specific
markers.
Recently,
however,
a
growing
body
evidence
has
revealed
that
play
various
important
roles:
development
and
maintenance
blood-brain
barrier
(BBB),
regulation
neurovascular
system
(e.g.,
vascular
stability,
vessel
formation,
cerebral
blood
flow,
etc.),
trafficking
inflammatory
cells,
clearance
toxic
waste
products
from
brain,
acquisition
stem
cell-like
properties.
In
unit,
perform
these
functions
through
coordinated
crosstalk
with
neighboring
including
endothelial,
glial,
neuronal
cells.
Dysfunction
contribute
wide
variety
diseases
lead
cognitive
impairments
such
as
small
disease
(SVD),
acute
stroke,
Alzheimer’s
(AD),
other
neurological
disorders.
For
instance,
SVDs,
pericyte
degeneration
leads
microvessel
instability
demyelination
while
constriction
after
ischemia
causes
no-reflow
phenomenon
brain
capillaries.
AD,
which
shares
some
common
risk
factors
dementia,
reduction
coverage
subsequent
microvascular
observed
association
white
matter
attenuation
impaired
cognition.
Pericyte
loss
BBB-breakdown,
stagnates
amyloid
β
leakage
neurotoxic
molecules
into
parenchyma.
this
review,
we
first
summarize
characteristics
pericytes,
their
roles
central
nervous
system.
Then,
focus
on
how
dysfunctional
pathogenesis
impairment
‘small
vessel’
‘large
diseases,
well
AD.
Finally,
discuss
therapeutic
implications
for
disorders
by
targeting
pericytes.
Journal of Neurochemistry,
Journal Year:
2019,
Volume and Issue:
151(2), P. 139 - 165
Published: July 18, 2019
Abstract
The
past
20
years
have
resulted
in
unprecedented
progress
understanding
brain
energy
metabolism
and
its
role
health
disease.
In
this
review,
which
was
initiated
at
the
14th
International
Society
for
Neurochemistry
Advanced
School,
we
address
basic
concepts
of
approach
question
why
has
high
expenditure.
Our
review
illustrates
that
vertebrate
a
need
because
number
neurons
to
maintain
delicate
interplay
between
metabolism,
neurotransmission,
plasticity.
Disturbances
energetic
balance,
mitochondria
quality
control
or
glia–neuron
metabolic
interaction
may
lead
circuit
malfunction
even
severe
disorders
CNS
.
We
cover
neuronal
consumption
neural
transmission
(‘housekeeping’)
cellular
processes.
Additionally,
describe
most
common
(glucose)
alternative
sources
namely
glutamate,
lactate,
ketone
bodies,
medium
chain
fatty
acids.
discuss
multifaceted
non‐neuronal
cells
transport
substrates
from
circulation
(pericytes
astrocytes)
supply
(astrocytes
microglia)
usage
different
fuels.
Finally,
pathological
consequences
disrupted
homeostasis
image
Frontiers in Immunology,
Journal Year:
2020,
Volume and Issue:
11
Published: Dec. 16, 2020
Chimeric
antigen
receptor
(CAR)
T
cells
provide
new
therapeutic
options
for
patients
with
relapsed/refractory
hematologic
malignancies.
However,
neurotoxicity
is
a
frequent,
and
potentially
fatal,
complication.
The
spectrum
of
manifestations
ranges
from
delirium
language
dysfunction
to
seizures,
coma,
fatal
cerebral
edema.
This
novel
syndrome
has
been
designated
immune
effector
cell-associated
(ICANS).
In
this
review,
we
draw
an
arc
our
current
understanding
how
systemic
local
cytokine
release
act
on
the
CNS,
toward
possible
preventive
approaches.
We
systematically
review
reported
correlations
secreted
inflammatory
mediators
in
serum/plasma
cerebrospinal
fluid
risk
ICANS
receiving
CAR
cell
therapy.
Possible
pathophysiologic
impacts
CNS
are
covered
detail
most
promising
candidate
cytokines,
including
IL-1,
IL-6,
IL-15,
GM-CSF.
To
insight
into
final
common
pathways
inflammation,
place
context
other
conditions
that
associated
neurologic
dysfunction,
sepsis-associated
encephalopathy,
malaria,
thrombotic
microangiopathy,
infections,
hepatic
encephalopathy.
then
what
known
about
interaction
components
neurovascular
unit,
endothelial
cells,
pericytes,
astrocytes,
microglia
neurons
respond
challenges.
Current
approaches,
corticosteroids
blockade
IL-1
IL-6
signaling,
reviewed
role
cytokines
ICANS.
Throughout,
point
out
gaps
knowledge
approaches
investigation
mechanism,
prevention,
treatment